Keywords
extracorporeal cardiopulmonary resuscitation, ECPR, extracorporeal life support, ECMO, out-of-hospital cardiac arrest, in-hospital cardiac arrest
This article is included in the Health Services gateway.
extracorporeal cardiopulmonary resuscitation, ECPR, extracorporeal life support, ECMO, out-of-hospital cardiac arrest, in-hospital cardiac arrest
Cardiac arrest (CA) is one of the leading causes of death worldwide.1,2 CA prevalence accounts for nearly 350,000 cases in the US,3 and whether out-of-hospital (OHCA)4–6 or in-hospital CA (IHCA),7,8 cardiac arrest is responsible for the morality of more than half a million individuals every year worldwide.9,10 Although adult CA survival rates have increased over the past 20 years, only just 22% of IHCA patients and less than 10% of OHCA patients survive.11,12 Notably, less than 10% of survivors have satisfactory neurological outcomes when discharged from hospitals despite standardizing basic cardiac resuscitation, post-arrest care, and application with personalized therapies.3,13 Extracorporeal cardiopulmonary resuscitation (ECPR) is a potentially life-saving therapy for patients in cardiac arrest who otherwise are unresponsive to traditional cardiopulmonary resuscitation (CPR).14,15 ECPR involves cardiopulmonary bypass maintaining circulation and perfusion to vital organs while16 the patient’s body recovers from the underlying condition that caused the cardiac arrest.17–19
Currently, ECPR is not considered a standard of care for cardiac arrest patients,20 and it is typically reserved for cases where conventional CPR has failed to restore a patient’s heart rhythm.21,22 There is growing evidence to suggest that ECPR may be a more effective treatment for certain types of cardiac arrest,23 particularly those caused by conditions such as pulmonary embolism, hypothermia, or drug overdose.24 As a result, some healthcare systems consider ECPR as an essential standard of care for cardiac arrest patients.25 For instance, in some parts of the world, emergency medical services have implemented ECPR programs that allow trained responders to perform the procedure on eligible patients in the field.26–28 While use of ECPR as a standard of care for cardiac arrest is still the subject of ongoing research, it is clear that this therapy has potential to save many lives. In this regard, our literature review aims to explore the efficacy of ECPR as a potential standard of care for cardiac arrest patients in the future.
We adhered to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) standards to prepare this literature review.29 Bibliographic searches were conducted using four electronic databases: PubMed, Google Scholar, Cochrane, and IEEE Explore.
Using a set of keywords, computerized bibliographic searches were carried out in PubMed, Google Scholar, Cochrane, and IEEE Explore. The search was limited to English language articles dating from 2010 to 2023. We utilized the following search terms: (“extracorporeal cardiopulmonary resuscitation” OR “ECPR” OR “extracorporeal oxygenation” OR “extracorporeal life support” OR “percutaneous cardiopulmonary support” OR “ECMO” OR “extracorporeal circulation”) AND (“cardiopulmonary resuscitation” OR “CPR” OR “conventional CPR” OR “CCPR”) AND (“out-of-hospital cardiac arrest” OR “in-hospital cardiac arrest” OR “cardiac arrest” OR “heart arrest” OR “OHCA” OR “IHCA”).
Articles were included in this literature review for fulfilling following criteria:
• Empirical primary studies evaluating ECPR in human subjects with either IHCA or OHCA.
• Articles published in English between 2010 and 2023.
• Articles exploring ECPR in cardiac arrest across all ages of patients.
Studies were eliminated based on the following exclusion criteria:
Each eligible publication’s study characteristics and data were extracted by us in adherence to the PICO framework.30 These characteristics and data included the first author’s name, the publication year, the country of origin, the study’s design, the location of the arrest (OHCA or IHCA), the number of patients, the sex ratio, and the mean age.
Authors pooled the findings from the included articles, and the results of all the research under consideration were then available for synthesis and analysis. A modified version of the Newcastle-Ottawa Quality Assessment Scale for Cohort Studies was used to rate effectiveness of each study (NOS)31 (Table 1).
Study | Selection (Maximum 5 points) | Comparability (Maximum 2 points) | Outcome (Maximum 3 points) | Total score | Quality |
---|---|---|---|---|---|
Bartos et al., 202032 | 4 | 2 | 2 | 8 | High |
Chandru et al., 202133 | 3 | 1 | 1 | 5 | Medium |
Djordjevic et al.,202134 | 4 | 1 | 1 | 6 | Medium |
Iwashita et al., 202035 | 5 | 1 | 2 | 8 | High |
Kim et al., 201436 | 3 | 2 | 3 | 8 | High |
Nee et al., 202037 | 3 | 2 | 1 | 6 | Medium |
Patricio et al., 201938 | 3 | 2 | 2 | 7 | High |
Poppe et al., 202039 | 4 | 1 | 3 | 8 | High |
Read et al. 202240 | 4 | 2 | 1 | 7 | High |
Schober et al., 201741 | 3 | 2 | 2 | 7 | High |
ter Avest et al., 202242 | 3 | 2 | 3 | 8 | High |
Yu et al., 201843 | 4 | 1 | 1 | 6 | Medium |
A total of 1,092 pertinent articles were found in the literature search across four electronic databases. The authors eliminated 373 duplicate articles. The remaining articles’ titles and abstracts were scrutinized for the research subject and 338 were excluded as these studies did not meet the research criteria. The remaining 381 articles were reduced to 140 after the inability to retrieve 241, and the remaining 140 were evaluated based on the predetermined eligibility standards. Eventually, only 12 articles met the requirements after being evaluated using the qualifying criteria (Tabulated in study characteristics in Table 2 and Table 3). The other 140 papers were disregarded on the grounds that 26 were published before 2010, 38 were non-English articles, 39 were abstracts and 25 were systematic reviews, letters to the editor, case reports, and magazines. The study selection process is shown in Figure 1.
Author, year | Setting, nation | Sample size (N) | Type of CA | Sex (Male/Female) | Mean age (years) |
---|---|---|---|---|---|
Bartos et al., 202032 | University of Minnesota, US | 160 consecutive VF/VT adult patients and 654 adults in the ALPS trial | OHCA | ECPR - 126/34 ALPS - 528/126 | ECPR - 57 ± 1.0 ALPS - 59 ± 0.4 |
Chandru et al. 202133 | Western Sydney Local Health District, Australia | 248 eligible CA comprised 89 VF, 9 VT, 85 PEA, and 57 Asystole. Bystander CPR = 175 | OHCA | 161/87 | 64 (IQR = 53-75) |
Djordjevic et al.,202134 | University Hospital Cologne, Germany | 44 patients | OHCA | 40/4 | 53 ± 12 |
Iwashita et al., 202035 | Auckland City Hospital, New Zealand | 328 patients | IHCA | 97/53 | 63.6 ± 16 |
Kim et al., 201436 | Korea University Medical Center, Korea | ECPR = 55 CCPR = 444 | OHCA | ECPR - 40/2 CCPR - 285/159 | EPCR - 53 (41–68) CCPR - 69 (56–77) |
Nee et al., 202037 | Charité Berlin, Germany | 254 consecutive patients | OHCA | 175/49 | 54 (43–64) |
Patricio et al., 201938 | Erasme University Hospital, Brussels, Belgium | ECPR = 112 CCPR = 80 | IHCA/OHCA | ECPR - 83/29 CCPR - 336/523 | CCPR - 65 ± 16 ECPR - 54 ± 16 |
Poppe et al., 202039 | Vienna, Austria | 92 patients | IHCA/OHCA | 72/20 | 48 (14) |
Read et al., 202240 | St Vincent's Hospital, Sydney, Australia | Pre-intervention = 27 Pos-intervention = 39 | IHCA/OHCA | Pre - 17/10 Post - 28/11 | Pre - 51 (3) Post - 55 (3) |
Schober et al., 201741 | Medical University of Vienna, Austria | 239 patients | OHCA | ECPR = 5/2 CCPR = 173/59 | ECPR - 46 (31–59) CCPR - 60 (50–70) |
ter Avest et al., 202242 | Kings College, UK | 162 patients | IHCA/OHCA | n/s | <60 |
Yu et al., 201843 | Taiwan University Hospital | 482 patients | IHCA/OHCA | 368/114 | 49.4 ± 11.8 |
Study | Study design | Study objectives | Intervention | Comparator | Evaluated outcome measures | Results |
---|---|---|---|---|---|---|
Bartos et al., 202032 | RS | To investigate the impact of resuscitation time on patient survival and metabolic profile during ECPR for VF/VT OHCA | ECPR | ALPS-CPR | The survival rate, resuscitation duration, and metabolic changes. | Neurologically favorable survival in ECPR than in ALPS patients (33% versus 23%; P = 0.01) with a longer mean duration (60 minutes versus 35 minutes; P < 0.001) |
Chandru et al., 202133 | OS | To predict the likely future caseload of ECMO at historically "low volume" centers. | ECPR | Bystander CPR | ROSC rates and survival rates. | Survival for VF, VT, PEA, and asystole was 43, 33, 9.4, and 8.7%, respectively. ROSC rates for VF, VT, PEA, and asystole were 64, 66, 55.3, and 42.1%, respectively. |
Djordjevic et al.,202134 | RS | ECPR outcomes and risk factors for OHC | ECPR | n/s | Survival and risk factors | 10 (23%) patients discharged and shorter pre-hospital CPR duration (60 (59;60) min (S) vs. 60 (55;90) min (NS), p = 0.07) |
Iwashita et al., 202035 | RS | ECPR for advanced cardiac support | ECPR | n/s | Survival and ECPR-eligibility | Seven (10.8%) were eligible, and one survivor |
Kim et al., 201436 | RS | To identify indicators predicting good neurologic outcomes, determine the ideal CPR duration to initiate ECPR as an alternate. | ECPR | CCPR | The optimal duration and predicting neurologic outcome. | CPR of <21 minutes is recommended for a satisfactory neurologic result. |
Nee et al., 202037 | PCS | ECPR efficacy | ECPR | n/s | ROSC and survival | Survivors18 had considerably less acidosis (pH 7.2 (IQR 7.15-7.4) vs. 7.0), and shorter times between collapse and the beginning of ECPR (58 min (IQR 12-85) vs. 90 min (IQR 74-114). |
Patricio et al., 201938 | RS | To compare ECPR and CCPR for patients with refractory CA | ECPR | CCPR | ROSC, ECMO, survival, and death | The ROSC rate = 54 min and 22 sec (77/80, 96%) and 54 min and 19 sec (30/80, 38%) for CCPR. the survival rate to ICU discharge was ECPR 18/80 (23%) vs. CCPR 14/80 (18%) (p = 0.42). |
Poppe et al., 202039 | RS | Validation of ECPR criteria | ECPR | n/s | ECPR eligibility, six criteria checklists. | Twenty-seven patients met all criteria and had 30-day survival noticeably higher [OR 6.0 (95% CI 1.78 to 20.19)]. P ¼ 0.004 |
Read et al. 202240 | RS | Evaluating the relationship between ECPR use, ROSC, and neurologically stable survival | ECPR | n/s | CPC, ROSC, survival, and time to ECMO | OHCA to ECMO decreased from 87 (IQR 78-95) to 70 (IQR 69-72) minutes post-intervention (p = 0.002). The median duration from IHCA to ECMO was 40 (IQR 20-75) to 28 (IQR 16-41) minutes (p = 0.134). Pre-survival 25.9% (7/27), post-survival 38.5% (15/39) (p = 0.288). |
Schober et al., 201741 | RS | To assess the qualities of the ECPR-eligible patients | ECPR | CCPR | ECPR selection and 180 days survival | ECPR patients had shorter pre-CPR intervals (0 vs. 1 min; p = 0.013), faster ED admission (38 vs. 56 min; p = 0.31), and younger (46 vs. 60 years; p = 0.04). Survival to discharge 14 (6%). |
ter Avest et al., 202242 | RS | Efficacy of HEMS' OHCA ECPR for IHCA | ECPR | n/s | ROSC and eligible ECPR patients | ROSC was 60 (37%) and 15 (9%) asystole deterioration. |
Yu et al., 201843 | PCS | Efficacy of ECPR | ECPR | n/s | Survival, ECMO, and ROSC | Favorable outcomes across various subgroups. |
The NOS Scale was used to assess the quality of the collected studies and considered ten factors: selection, comparability, and outcome and rating each study on a range of 0 to 10. High-quality observational cohort studies constituted those with 7 or more stars; a score of less than four denotes low quality, a score of five to six suggests moderate quality, a score of seven to eight indicates good quality, and a score of nine to 10 denotes extremely good quality.44 Four studies were deemed moderate quality, while eight were judged to be of high quality. No studies were deemed to be of low quality. The quality assessment score is shown in Table 1.
The main objective of the current literature review is to examine the efficacy of ECPR compared to conventional CPR in patients with cardiac arrest across various settings. In doing so, we aim to establish the effectiveness of ECPR as a future intervention for either IHCA or OHCA patients. We also identified the existing gaps that would require further research. Based on the synthesis of included studies, our review showed that employing ECPR in both IHCA and OHCA is associated with improved survival rate and corresponding positive neurological outcomes compared to conventional CPR. Our review entails a total of twelve studies comprising observational and retrospective studies, analyzing a cumulative of 2,897 IHCA and OHCA patients. Six studies examined ECPR in OHCA, while the remaining six explored IHA and OHCA. The outcome measures evaluated across the studies mainly comprised ROSC (return of spontaneous circulation), survival, neurological outcomes, eligibility for ECPR, and time to extra corporeal membrane oxygenation (ECMO). Furthermore, among the 12 studies analyzed, five studies reported an increased long-term neurologically intact survival with the use of ECPR, four of which were OHCA,32,34,37,39 while one evaluated ECPR in IHCA35 (Table 3 in Supplemental Material shows the studies’ design, objectives, interventions, outcomes, and results with neurological outcomes.)
Generally, studies enrolling adult IHCA and OHCA patients reported improved and favorable neurological outcomes associated with ECPR.38,40 A study by Bartos et al. demonstrated that for CPR durations of less than 60 minutes, ECPR was associated with favorable neurological outcomes and survival despite significantly higher metabolic derangement as compared with CCPR.32 Our observations are consistent with findings of another meta-analysis which compared ECPR and CCPR for patients with CA and found that ECPR was related to statistically significant improvement, 30-day survival, and neurologic outcomes for patients with IHCA (RR = 1.60, 95% CI = 1.25-2.06 and RR = 2.69, 95% CI = 1.63-4.46).45 The findings revealed no effect on neurological outcomes and survival with ECPR on OHCA patients.45 However, another study comparing ECPR and CCPR revealed that neurological outcome and survival were the same in both groups for OHCA.46 This finding particularly contradicts the outcomes of the majority of the included studies, which suggest favorable neurological outcomes associated with ECPR relative to CCPR.36,43
The disparities in these results can be attributed to selection bias in meta-analyses which are due to inclusion of studies with recruitment periods spanning a decade, a period in which technological advancements could have changed a lot in this field. For instance, these advancements have seen CPR guidelines being changed twice and the emergence of advanced mechanical CPR equipment becoming widely adopted.47 While our literature review evaluated the criteria under which ECPR should be performed, four studies reported the need to evaluate CA patients for eligibility to see if they fit for ECPR therapy.35,39,41,42 These studies report higher survival associated with carefully selected patients after meeting inclusion criteria.39 These results are significant as they demonstrate the need to make early patient selection conceivable and necessary prior to ECPR therapy. In that regard, Te Avest et al. suggest that one of the factors to consider is the effectiveness of in-hospital ECPR, which appears to be of little importance in rural setups, as potentially ECPR-eligible patients would deteriorate prior to their arrival to the hospital.42 This is imperative since as ECPR awareness grows and pre-hospital mechanical CPR is introduced, it is plausible that not only more ECPR eligible cases will present to the emergency department (ED), but may also predict a rise in ECPR ineligible patients.48
Time to return of spontaneous circulation, ROSC, CPR duration, and extracorporeal membrane oxygenation were evaluated as an effect of ECPR in this literature review and were reported in most of included articles. Kim et al. showed that longer durations of CPR were associated with decreased neurological outcomes in CCPR compared to with ECPR.36 In contrast, a significant number of patients who were scheduled for ECPR recovered ROSC before or after hospital admission after receiving prolonged CPR.37 In addition, Patricio et al. showed that the ROSC rates associated with ECPR were significantly higher relative to CCPR (77/80 (96%) vs. 30/80 (38%), (p <0.001)).38 Additionally, ECPR effectively reduced the time from OHCA to ECMO under an ECPR-specific program implementation.40 (Table 3 provided as in Supplemental Material shows the study design, objectives, interventions, outcomes, and results with neurological outcomes.)
The majority of the included studies were observational studies and retrospective in design. This literature review demonstrates existence of a research gap with the absence of randomized control trials, which would raise the level and quality of evidence and close knowledge gaps, since the majority of the current knowledge is derived from single-center observations, and the preponderance of the evidence is derived from case series and cohort studies, making it susceptible to publication bias.49 As a result of observational studies’ well-known flaws, it is impossible to draw valid conclusions from primary data due to its high bias risk and potential for producing accurate but false results when combined. This indicates the importance and need for high-quality research that would explore the viability and patient-centered results of employing ECPR in innovative settings, such as via EMS-based or ED-based large, randomized trials, further exploring the usefulness of ECPR for cardiac arrest. Ideally, the design of future research would identify a successful and unified approach to ECPR and develop an algorithm that could be used for both IHCA and OHCA.
Our literature review demonstrates that ECPR has better survival rates and neurological outcomes than standard CPR therapies for CA. ECPR is a development in CPR that allows a bridge to treatment in carefully chosen individuals after meeting the criteria following refractory CA. Furthermore, we establish that individuals who meet the criteria of selection for ECPR are associated with increased neurological outcomes and high survival rates compared to those who are not eligible. This study also demonstrates that, at the moment, ECPR is the most successful in centers with a well-trained multidisciplinary ECMO team of experts. On the other hand, cardiac arrest patients in semi-rural areas and underdeveloped locations are likely to benefit less from ECPR interventions due to the lack of necessary ECPR expertise and infrastructure. Those individuals eligible for ECPR benefit from better neurological outcomes and associated higher survival rates. Therefore, ECPR has the potential to be an effective standard of care for cardiac arrests in the future. There is a need for high quality research in this area to evaluate the feasibility, safety, and efficacy associated with ECPR and the reliability of the findings in our literature review.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the topic of the review discussed comprehensively in the context of the current literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Prehospital medical emergency care
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |
---|---|
1 | |
Version 1 14 Sep 23 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)